NIPH Clinical Trials Search

UMIN ID: UMIN000000732

Registered date:10/06/2007

Multicenter study of combination therapy using mizoribine, cyclosporin, basiliximab and steroids in kidney transplantation.

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedKidney transplantation
Date of first enrollment2006/06/01
Target sample size70
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)cyclosporinbasiliximab + steroids + mizoribine


Primary OutcomeIncidence of virus infection
Secondary OutcomeRejection reactions (incidence, types, severity), patient survival rate, graft suvival rate, incidence of adverse events / abnormalities in the laboratory values.

Key inclusion & exclusion criteria

Age minimum2years-old
Age maximum70years-old
GenderMale and Female
Include criteria
Exclude criteria1.The patient who has a history of hypersensitivity against components of either one of the following drugs: Bredinin tablet, Neoral or Simulect. 2.The patient who is pregnant or a female patient who is expecting to become pregnant. 3.The patients who showed a positive result with cross match test. 4.The patient who recived ABO incompatible donor. 5.The patient with whom the physician-in-charge considered inappropriate as a subject of this study.

Related Information


public contact
Address Japan
Telephone 03-5919-3825
Affiliation MNKT Forum Keio University Department of Urolgy
scientific contact
Name Akira Hasegawa
Address 6-11-1 Omori-nishi Ota-ku,Tokyo,Japan Japan
Affiliation Toho University School of Medicine